Topic: Watson Pharmaceuticals Inc.
WPI) today announced that the U.S. pilot study evaluating Uracyst (sodium chondroitin sulfate solution 2.0%) for the treatment of interstitial cystitis did not meet predefined efficacy endpoints.. Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company. Statements contained in this press ...
Paragraph MORRISTOWN, N.J., Oct. 5 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 ...
Watson Pharmaceuticals Inc. (WPI) reported second-quarter earnings of 83 cents per share, a couple cents above the Zacks Consensus Estimate and 13.7% above the year-ago earnings of 73 cents.. Watson Pharma expects Generic segment sales in the range of $2.25 - $2.35 ...
WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, has been sued by Pfizer Inc. and Wyeth Pharmaceuticals Inc. in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for sirolimus tablets in the 1 mg and 2 ...
WPI), a leader in generic and specialty branded pharmaceuticals, announced today that G. Frederick Wilkinson has joined the Company as Executive Vice President, Global Brands. Mr. Wilkinson will report directly to Paul Bisaro, President and Chief Executive Officer.. Most recently, Mr. Wilkinson ...
Watson Pharma gets FDA approval for generic Toprol XL and says it will launch drug immediatelyWatson Pharmaceuticals Inc. said Monday it received approval for a generic version of the high blood pressure and angina drug Toprol XL, and plans to begin shipping ...
Watson Pharmaceuticals' CFO takes leave of absence, health reasons citedWatson Pharmaceuticals Inc. said Monday Chief Financial Officer Mark W. Durand has taken a leave of absence due to health reasons.R. Todd Joyce, vice president, controller and treasurer, has been appointed acting principal ...
Watson Pharmaceuticals gets FDA approval for generic Plan B emergency contraceptiveWatson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals' Plan B emergency contraceptive.The generic version is approved for prescription use only.Duramed has ...
Many billions of dollars will be up for grabs in coming years as big-selling drugs go off patent and emerging markets increase their spending on pharmaceuticals. Last week brought news of one acquisition in the sector - Watson Pharmaceuticals' ....
Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock, getting access to a promising drug candidate pipeline and new markets.Watson of Morristown, N.J., said the combined company will have about ...
From Around the Web
Video Gallery
-
Cephalon pharmaceuticals
Cephalon pharmaceuticals - link to online store drugshost.com Modalert (Modafinil ...2011-12-02 -
Watson Pharmaceuticals Acquires Specifar For $562 ...
Watson Pharmaceuticals, Inc. (NYSE:WPI) announced today it has acquired ...2011-05-25 -
Watson Pharmaceuticals Powers a Continuous Learnin...
California-based Watson Pharmaceuticals Inc. takes innovative steps to prepare its ...2010-08-12
